title: Insulin therapy in type 1 diabetes.
abstract: Although not curable, type 1 diabetes is eminently controllable. IIT, as guided by the results of landmark studies such as the DCCT, provides primary care providers with a blueprint for reducing the frequency of the devastating complications of diabetes that were all too common in the recent past. Considering the remarkable advances in contemporary therapy, including MDI and CSII, the likelihood of even greater future improvements in quality of life and survivability can be anticipated. Success requires patient engagement and education, an informed primary care provider, and an interdisciplinary team to maximize the benefits of insulin therapy and avoid the risks of hypoglycemia.
authors.affiliation: Providence Medical Group NE-Medical Education, 5050 Northeast Hoyt, Suite 540, Portland, OR 97213, USA; Department of Internal Medicine, Oregon Health and Sciences University, Portland, OR, USA. Electronic address: Elizabeth.Stephens@providence.org.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Stephens
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D048909:Diabetes Complications / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D019468:Disease Management; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D010353:Patient Education as Topic; D011788:Quality of Life
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin
keywords: Carbohydrate counting; Diabetes; Glucose monitoring; Hypoglycemia; Insulin